<DOC>
	<DOC>NCT00191815</DOC>
	<brief_summary>The purpose of this study is to determine the objective tumor response of the first-line therapy combination of gemcitabine and cisplatin in patients with metastatic breast cancer</brief_summary>
	<brief_title>Combination Chemotherapy for Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>You are female in the age of 18 to 75 years old. You have been diagnosed with the metastatic breast cancer. You have desire and an opportunity to visit your doctor in medical site, both during realization of the active treatment program, and within 24 months of medical follow up. You must sign this informed consent form You are pregnant or breastfeeding. Your laboratory parameters fall outside the limits, admitted by requirements of the present clinical study. You have been diagnosed with serious concomitant or acute infectious disease. You have used experimental medications within the last month.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>